Abstract:Abstract Background Population-based studies are crucial for gaining insights into epidemiology, risk factors, and outcomes of IBD. However, studies that characterize patient cohorts typically analyze a single resource, apply diverse eligibility criteria, and extract different sets of attributes. This study aims to address this gap by employing a unified data and analysis framework developed by the Observational Health Data Sciences and Informatics (OHDSI) community to longitudinally describe and compare IBD patient cohorts across multiple geographic regions. Methods Using routinely collected healthcare data harmonized to the OMOP Common Data Model, we longitudinally characterized IBD patient cohorts across diverse geographic regions. Data sources included insurance claims and electronic health records from primary and tertiary settings. IBD cohorts were defined based on diagnoses and medications, and stratified into various groups (e.g. by sex and age at diagnosis). Results We characterized disease trajectory of 462,502 Crohn’s disease (CD) and 589,118 ulcerative colitis (UC) subjects, in 16 databases (DBs) from seven countries worldwide (table 1). There was a noticeable trend toward a decrease in the average age at CD diagnosis in Europe and North America (e.g., 47.5 in 2005-2010 period to 44.3 in 2020-2022 at a US DB) contrasting with more stable patterns in Southeast Asia (e.g., 33.7 to 33.9 respectively in Japan). A similar, though weaker, decrease in diagnosis age has been observed in UC subjects. Prevalence rates of pre-diagnosis symptoms (abdominal pain, diarrhea, and rectal bleeding) were relatively stable over time, with minor differences between DBs. The proportion of females with anxiety was consistently higher across all datasets compared to males. Similarly, depression prevalence ranged between 11% to 46% in females and 0% to 33% in males. Examining surgical outcomes for CD patients, our study uncovered nuanced trends. While there hasn't been a significant decrease in colonic resection rates within one year following diagnosis between the early 2000s and 2020 in US populations, some DBs demonstrated increased resection rates over time (from 11% in 2005 to 14% in 2020 and from 5% to 11% in two different US DBs). A similar trend was observed when examining the colonic resection rate 3 years post diagnosis. Small bowel resection rates were stable along time among most DBs one- and three-years following diagnosis. Conclusion This study, leveraging OHDSI network data and tools, provides a comprehensive characterization of IBD patient cohorts from various areas. It furnishes valuable insights into disease trends, demographic variations, outcome, and pre-diagnosis symptoms in CD and UC contributing to a deeper understanding of IBD epidemiology

S1273 Seasonal Variation in Hospital Admissions, Length of Stay and Mortality for Patients With Inflammatory Bowel Disease

S1063 Inflammatory Bowel Disease Mortality: A Cross-Sectional Analysis of Rural and Urban Disparities 1999-2020

S1455 Seasonal Variation of Crohn's Exacerbations in the Tennessee River Valley

Clinical Characteristics of 379 Patients with Inflammatory Bowel Disease

Clinical Presentation of Inflammatory Bowel Disease： a Hospital Based Retrospective Study of 379 Patients in Eastern China

P446 Influence of seasonal vitamin D deficit in clinical course of inflammatory bowel disease patients

S1296 Unveiling the Postpartum Peril: Assessing Inflammatory Bowel Disease's Impact on Hospital Readmissions

P675 Associations Between Inflammatory Bowel Disease, Social Isolation, and Mortality: Evidence from UK Biobank Cohort Study

P479 Trends in Medication Use and Treatment Patterns in Chinese Patients with Inflammatory Bowel Diseases: A Multicenter Cohort Study from 1999 to 2020

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

S1215 Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease-Related Mortality: An Analysis of Disparities 2020-2022

Inflammatory bowel disease evolution in the past two decades: a chronological multinational study

Understanding patient variability to biologic treatments in inflammatory bowel disease

Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020

S991 Increasing Mortality of Inflammatory Bowel Disease in Women: A Population-Based Time-Trend Analysis Using the Global Burden of Diseases Database, 1990-2019

Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses

MORTALITY IN INFLAMMATORY BOWEL DISEASE: A LONGITUDINAL POPULATION-BASED STUDY IN THE UNITED STATES

P1156 Characteristics and outcomes of over a million Inflammatory Bowel Disease patients in seven countries: a multinational cohort study

Prevalence of Metabolic Syndrome and Its Association with Cardiovascular Outcomes in Hospitalized Patients with Inflammatory Bowel Disease

P347 A Trend Analysis of Inflammatory Bowel Disease in Non-Endemic Era (1993-2023)

S1074 Impact of Inflammatory Bowel Disease on the Outcomes of Pregnancy: A National Inpatient Sample Analysis